Spots Global Cancer Trial Database for esophageal diseases
Every month we try and update this database with for esophageal diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | NCT03549494 | Stomach Neoplas... Gastrointestina... Digestive Syste... Esophageal Neop... Head and Neck N... Gastrointestina... Digestive Syste... Esophageal Dise... Stomach Disease... Esophagogastric... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy | NCT03859557 | GERD Barrett Esophag... Low Grade Esoph... Esophageal Dise... | 18 Years - | CDx Diagnostics | ||
| Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. | NCT05624099 | Esophageal Neop... Esophageal Dise... Digestive Syste... | camrelizumab Paclitaxel drug... Platinum drug Radiation | 18 Years - 75 Years | Fujian Cancer Hospital | |
| CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer | NCT04481100 | Esophageal Neop... Esophageal Dise... Esophageal Squa... | itraconazole | 18 Years - 75 Years | Hangzhou Cancer Hospital | |
| Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus | NCT00208936 | Esophageal Dise... | Taxol, Cisplati... | 18 Years - | Emory University | |
| The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry | NCT02988934 | Barrett Esophag... Gastroesophagea... Esophageal Dysp... Esophageal Dise... | 18 Years - 80 Years | CDx Diagnostics | ||
| Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) | NCT03962179 | Perforation Eso... Esophageal Canc... Esophageal Acha... Esophageal Dise... | VACStent | 18 Years - | University Hospital of Cologne | |
| The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy | NCT03859557 | GERD Barrett Esophag... Low Grade Esoph... Esophageal Dise... | 18 Years - | CDx Diagnostics | ||
| Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction | NCT00442507 | Esophageal Neop... Esophageal Dise... | Erlotinib Avastin | 18 Years - | Washington University School of Medicine | |
| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | NCT05252078 | Esophageal Squa... Esophageal Neop... Esophageal Dise... Gastrointestina... Gastrointestina... Digestive Syste... Digestive Syste... Neoplasms by Si... Neoplasms by Hi... Neoplasms, Squa... Carcinoma, Squa... | Anlotinib hydro... TQB2450 | 18 Years - | Jiangxi Provincial Cancer Hospital | |
| Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans | NCT05591053 | Esophagus Cance... Esophageal Canc... Esophageal Neop... Esophageal Dise... Esophageal Aden... Esophageal Squa... Esophagus SCC Esophagus Tumor Esophagus Adeno... Esophagus Neopl... | ActivSight | 18 Years - | Activ Surgical | |
| Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | NCT00526331 | Esophageal Dise... Gastrointestina... Disorder of the... Gynecologic Dis... Kidney Diseases Liver Diseases Pancreatic Dise... Prostate Cancer Spinal Disease | Vigileo Monitor FloTrac Sensor | 18 Years - | M.D. Anderson Cancer Center | |
| Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma | NCT03817567 | Esophageal Squa... | recombinant ant... | 18 Years - 75 Years | Sinocelltech Ltd. | |
| Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | NCT03549494 | Stomach Neoplas... Gastrointestina... Digestive Syste... Esophageal Neop... Head and Neck N... Gastrointestina... Digestive Syste... Esophageal Dise... Stomach Disease... Esophagogastric... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. | NCT06365866 | Esophageal Neop... Head and Neck N... Gastrointestina... Digestive Syste... Digestive Syste... Esophageal Dise... Neoplasms by Si... Gastrointestina... Neoplasms | "BRAXX" Esophag... Add-on of intra... | 20 Years - 85 Years | Taipei Veterans General Hospital, Taiwan | |
| Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma | NCT03817567 | Esophageal Squa... | recombinant ant... | 18 Years - 75 Years | Sinocelltech Ltd. | |
| Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus | NCT00208936 | Esophageal Dise... | Taxol, Cisplati... | 18 Years - | Emory University | |
| Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma | NCT03817567 | Esophageal Squa... | recombinant ant... | 18 Years - 75 Years | Sinocelltech Ltd. | |
| Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. | NCT05624099 | Esophageal Neop... Esophageal Dise... Digestive Syste... | camrelizumab Paclitaxel drug... Platinum drug Radiation | 18 Years - 75 Years | Fujian Cancer Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
